|
CN108866088A
|
|
Target CLL-1 Chimeric antigen receptor and application thereof
|
|
CN108728460A
|
|
Target the Chimeric antigen receptor and application thereof of GD2
|
|
CN108721331A
|
|
A kind of Chimeric antigen receptor T cell preparation and its Cord blood formulation preparation method
|
|
CN108864286A
|
|
Target CD19 Chimeric antigen receptor and the anti-antibody variable region PD1 of Combined expression method and and application thereof
|
|
CN108864287A
|
|
A kind of Chimeric antigen receptor targeting Mesothelin and the method and application thereof that its two kinds are modified
|
|
CN108864276A
|
|
Target the antibody variable region T cell receptor Combined expression PD1 and application thereof of NY-ESO-1
|
|
CN108728459A
|
|
Target the Chimeric antigen receptor of CD19 and the method and purposes of Combined expression IL-15
|
|
CN108728458A
|
|
Target the Chimeric antigen receptor of mesothelin and the method and purposes of Combined expression IL-15
|
|
CN108285489A
|
|
Target the Chimeric antigen receptor and application thereof of BCMA-BBz-tEGFR
|
|
CN108285920A
|
|
A kind of technology and application thereof of vivo detection CART cells expression
|
|
CN108070608A
|
|
Target Chimeric antigen receptor of CD19-CD28-tEGFR and application thereof
|
|
CN108070607A
|
|
Target Chimeric antigen receptor of CD19-41BB-tEGFR and application thereof
|
|
CN107964549A
|
|
Target Chimeric antigen receptor of CD22 and application thereof
|
